Company intelligence / Profile preview

Predictive Health

Ownership: Private
Development stage: Commercial

Overview

Predictive Health offers FDA-listed digital health platforms that use AI to remotely monitor patients after surgery to predict surgical site infection risks ("MyHealthPal") and provides specialty diagnostic tests like the PULS Cardiac Test to assess cardiovascular event risks. These tools are integrated with EMRs and designed for home use without additional devices.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: Device/software-based remote monitoring and diagnostics
Industry: Digital Health Medical Devices

Partnerships

Madison Core Laboratories—for distribution of PULS Cardiac Test™ across 30+ healthcare facilities in Alabama region.

Beyond the preview

Go deeper on Predictive Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Predictive Health.

Explore the full profile